KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 112 filers reported holding KEROS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $941,000 | -50.4% | 34,074 | -2.3% | 0.01% | -12.5% |
| Q1 2022 | $1,896,000 | -28.2% | 34,863 | -23.1% | 0.02% | -30.4% |
| Q4 2021 | $2,639,000 | +46.3% | 45,363 | 0.0% | 0.02% | +76.9% |
| Q3 2021 | $1,804,000 | +88.5% | 45,363 | +101.5% | 0.01% | +85.7% |
| Q2 2021 | $957,000 | -31.0% | 22,516 | 0.0% | 0.01% | -50.0% |
| Q1 2021 | $1,386,000 | -12.8% | 22,516 | 0.0% | 0.01% | -56.2% |
| Q4 2020 | $1,589,000 | +61.3% | 22,516 | -11.9% | 0.03% | +39.1% |
| Q3 2020 | $985,000 | – | 25,546 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,412,705 | $99,652,000 | 10.82% |
| CHI Advisors LLC | 433,852 | $30,604,000 | 8.62% |
| VR Adviser, LLC | 672,306 | $47,424,000 | 6.97% |
| Consonance Capital Management LP | 557,095 | $39,297,000 | 3.67% |
| Logos Global Management LP | 450,000 | $31,743,000 | 2.72% |
| RA Capital Management | 1,875,000 | $132,263,000 | 1.85% |
| Nantahala Capital Management | 534,514 | $37,705,000 | 1.17% |
| Orbimed Advisors | 1,679,417 | $118,466,000 | 1.04% |
| Eventide Asset Management | 346,000 | $24,407,000 | 0.37% |
| Atom Investors LP | 49,981 | $3,526,000 | 0.36% |